Amgen Czech Republic made a net profit of CZK 37.8 mil in 2017, up 20% compared to the previous year. Total sales reached CZK 417 mil, which is down 33.4% when compared to the previous year.
Historically, between 2005 and 2017, the company’s net profit reached a high of CZK 46.2 mil in 2011 and a low of CZK 5.00 mil in 2005. Over the last decade the firm's net profit increased by an average of 14.4% a year.
Sales have grown by 8.68% a year on average since 2007. They reached a high of CZK 637 mil in 2014 and a low of CZK 109 mil in 2005.
The company has been operating with an average EBITDA margin of 8.59% in the last 5 years and average net margin of 6.51%. The firm generated an average return on invested capital of 29.5% for its shareholders over the last five years.
You can see all the company’s data at Amgen Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
